Riskpilot← Back to searchSign inGet full accessViveka Nyman Fysioterapi AB
ABActiveOrg 5567899454Hagavägen 18Physiotherapy activities · NACE 8695Est. 20091 employees
Revenue 2024
SEK 1,4M
+8% vs 2023
EBITDA margin
15.0%
-34% vs 2023
Equity ratio
80.6%
Financial strength
Net profit 2024
SEK 182K
-31% vs 2023
| Revenue | SEK 1,4M | +8% |
| EBITDA | SEK 216K | -34% |
| Net profit | SEK 182K | -31% |
| Total assets | SEK 1M | +3% |
| Equity | SEK 820K | -2% |
| Employees | 1 | — |
Legal name
Viveka Nyman Fysioterapi AB
Org number
5567899454
Legal form
Aktiebolag
NACE code
8695 · Physiotherapy activities
Founded
29 september 2009
Share capital
SEK 100 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget ska bedriva hälso och sjukvård, fysioterapi, psykoterapi, utbildning, utgivning av böcker, viss försäljning av sjukvårdsprodukter samt därmed förenlig verksamhet.
Address
Hagavägen 18
Email
nymanviveka@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 1 359 | 1 274 | 1 240 | 1 327 | 1 440 |
| Staff expenses | — | — | −523 | −574 | −676 |
| EBITDA | 285 | 359 | 261 | 327 | 216 |
| Depreciation & amort. | −0 | −0 | — | — | — |
| EBIT | 285 | 359 | 261 | 327 | 216 |
| Net financials | 38 | — | −43 | 11 | 18 |
| Profit before tax | 323 | 359 | 218 | 338 | 234 |
| Tax | −67 | −78 | −59 | −73 | −52 |
| Net profit | 256 | 281 | 159 | 265 | 182 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 745 | 924 | 909 | 990 | 1 017 |
| Equity | 553 | 714 | 723 | 838 | 820 |
| Long-term debt | 0 | 0 | — | — | — |
| Short-term debt | 192 | 211 | 186 | 152 | 197 |
| Total debt | 192 | 211 | 186 | 152 | 197 |
EBITDA margin
15.0%
This company
15.8%
Market median
-5% vs market
20202024
Equity ratio
80.6%
This company
38.2%
Market median
+111% vs market
20202024
Return on equity
22.2%
This company
18.4%
Market median
+21% vs market
20202024
Net profit margin
12.7%
This company
8.1%
Market median
+57% vs market
20202024
Asset turnover
1.42×
This company
1.12×
Market median
+27% vs market
20202024
Debt / equity
0.24×
This company
0.62×
Market median
+61% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
IV Chief Executive Officer | Chief Executive Officer | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Viveka Nyman Fysioterapi AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Ingrid Viveka Nyman | Chief Executive Officer | 0 companies |
| Anders Ebbe Nyman | Deputy Board Member | 0 companies |